Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,984 | -6,521 | -3,824 | -2,146 | -11,393 |
| Depreciation Amortization | 672 | 381 | 257 | 137 | 584 |
| Accounts receivable | 48 | 3 | -4 | -17 | 90 |
| Accounts payable and accrued liabilities | 94 | 258 | -699 | -359 | -84 |
| Other Working Capital | 11 | -145 | -1,032 | -518 | 460 |
| Other Operating Activity | 887 | 1,527 | 2,299 | 1,365 | 3,334 |
| Operating Cash Flow | $-6,272 | $-4,497 | $-3,002 | $-1,536 | $-7,009 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -12 | -21 | N/A | -117 |
| Other Investing Activity | 3,602 | 3,602 | 3,541 | 0 | 409 |
| Investing Cash Flow | $3,601 | $3,590 | $3,520 | $N/A | $292 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,125 | 2,125 | 2,125 | N/A | 1,075 |
| Common Stock Issued | 1,820 | 1,820 | N/A | 1,575 | 5,764 |
| Common Stock Repurchased | -180 | -180 | N/A | N/A | N/A |
| Other Financing Activity | -70 | -70 | 0 | 0 | 0 |
| Financing Cash Flow | $3,695 | $3,695 | $2,125 | $1,575 | $6,839 |
| Exchange Rate Effect | 219 | -34 | -47 | -49 | -271 |
| Beginning Cash Position | 544 | 544 | 544 | 544 | 693 |
| End Cash Position | 1,786 | 3,297 | 3,139 | 533 | 544 |
| Net Cash Flow | $1,243 | $2,754 | $2,595 | $-11 | $-149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,272 | -4,497 | -3,002 | -1,536 | -7,009 |
| Capital Expenditure | -10 | -21 | -21 | N/A | -117 |
| Free Cash Flow | -6,282 | -4,518 | -3,023 | -1,536 | -7,126 |